News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At The American College of Cardiology’s 63rd Annual Scientific Session


3/31/2014 6:44:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Catabasis Pharmaceuticals Inc. today announced that data from a Phase 1 clinical trial of its lead development candidate, CAT-2003, will be presented at the American College of Cardiology’s 63rd Annual Scientific Session (ACC.14) in Washington, D.C. Catabasis’ chief medical officer, Joanne Donovan, M.D., Ph.D., will discuss the clinical data during the poster session from 9:45 to 10:30 a.m. EDT on Monday, March 31.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES